Edgar Filing: CARDINAL HEALTH INC

================================================================================

SCHEDULE 14A
(RULE 14A-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934
(AMENDMENT NO. )

Filed by the Registrant [X]

Filed by a Party other than the Registrant [ ]

Check the appropriate box:

[ ] Preliminary Proxy Statement [ ] CONFIDENTIAL, FOR USE OF THE COMMISSION
ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
[x] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12.

CARDINAL HEALTH, INC.
(NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

XXXXXXXXXXXXXXXX
(NAME OF PERSON(S) FILING PROXY STATEMENT, IF OTHER THAN THE REGISTRANT)

Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1) Title of each class of securities to which transaction applies: .......

(2) Aggregate number of securities to which transaction applies: ..........

(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
filing fee is calculated and state how it was determined): ............

(4) Proposed maximum aggregate value of transaction: ......................

(5) Total fee paid: .......................................................

[ ] Fee paid previously with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.

(1) Amount Previously Paid: ...............................................

(2) Form, Schedule or Registration Statement No.: .........................

(3) Filing Party: .........................................................

(4) Date Filed: ...........................................................

================================================================================

[Cardinal Health Logo]

---------------------

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD NOVEMBER 6, 2002

----------------------

Notice is hereby given that the Annual Meeting of Shareholders of
Cardinal Health, Inc., an Ohio corporation (the "Company"), will be held at the
Company's corporate offices at 7000 Cardinal Place, Dublin, Ohio, on Wednesday,
November 6, 2002, at 11:30 a.m., local time, for the following purposes:

1. To elect five Directors, each to serve for a term of three years and
until his or her successor is duly elected and qualified; and

2. To transact such other business as may properly come before the
meeting or any adjournment or postponement thereof.

THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE FOR THE ELECTION OF THE
FIVE DIRECTORS LISTED IN ITEM 1.

Only shareholders of record on September 9, 2002 are entitled to notice
of and to vote at the meeting or any adjournment or postponement thereof.

By Order of the Board of Directors.

/s/ PAUL S. WILLIAMS, Secretary

October 10, 2002

SHAREHOLDERS, WHETHER OR NOT THEY EXPECT TO ATTEND THE MEETING IN
PERSON, ARE URGED TO COMPLETE, DATE AND SIGN THE ENCLOSED PROXY AND RETURN IT IN
THE ENCLOSED POSTAGE-PAID ENVELOPE, OR TO VOTE BY TELEPHONE OR INTERNET PURSUANT
TO INSTRUCTIONS PROVIDED WITH THE PROXY CARD.

[Cardinal Health Logo]

PROXY STATEMENT

This Proxy Statement is being furnished in connection with the
solicitation of proxies on behalf of the Board of Directors of Cardinal Health,
Inc., an Ohio corporation (the "Company"), for use at the annual meeting of the
shareholders of the Company (the "Annual Meeting") to be held on Wednesday,
November 6, 2002, at the offices of the Company, located at 7000 Cardinal Place,
Dublin, Ohio 43017, at 11:30 a.m. local time and at any adjournment or
postponement thereof. This Proxy Statement and the accompanying proxy, together
with the Company's Annual Report to Shareholders for the fiscal year ended June
30, 2002 ("FY02"), are first being sent to shareholders of the Company on or
about October 10, 2002.

The close of business on September 9, 2002, has been fixed as the record
date for the determination of shareholders of the Company entitled to notice of
and to vote at the Annual Meeting. At that date, the Company had outstanding
444,638,825 common shares, without par value ("Common Shares"). Except as set
forth below, holders of Common Shares at the record date are entitled to one
vote per share for the election of Directors and upon all matters on which
shareholders are entitled to vote.

The address of the Company's principal executive office is 7000 Cardinal
Place, Dublin, Ohio 43017.

ELECTION OF DIRECTORS

The Company's Board of Directors currently consists of fourteen members,
divided into three classes, two classes of five members each and one class of
four members. The Company's Restated Code of Regulations, as amended (the "Code
of Regulations"), currently provides that the number of Directors may be
increased or decreased by action of the Board of Directors upon the majority
vote of the Board, but in no case may the number of Directors be fewer than nine
or more than sixteen without an amendment to the Code of Regulations approved by
the affirmative vote of the holders of not less than 75% of the shares having
voting power with respect to the proposed amendment.

At the Annual Meeting, the Company's shareholders will be asked to vote
for the election of the five nominees hereinafter named, each to serve for a
term of three years and until his or her successor is duly elected and
qualified. (See PROPOSAL 1 below.) Common Shares represented by proxies, unless
otherwise specified, will be voted for the named nominees. If, by reason of
death or other unexpected occurrence, any one or more of the nominees should not
be available for election, the proxies will be voted for the election of any
substitute nominee(s) as the Board of Directors may propose. Proxies may not be
voted at the Annual Meeting for more than five nominees.

Under Ohio law, if notice in writing is given by any shareholder
entitled to vote at the Annual Meeting to the President, a Vice President or the
Secretary of the Company, not less than 48 hours before the scheduled time of
the meeting, that the shareholder desires the voting for election of Directors
be cumulative, and if an announcement of the request for cumulative voting is
made at the beginning of the meeting by the Chairman or Secretary, or by or on
behalf of the shareholder giving such notice, each shareholder entitled to vote
at the Annual Meeting will have the right to cumulate such voting power as he or
she possesses at such election and to give one nominee a number of votes equal
to the number of Directors to be elected multiplied by the number of shares he
or she holds, or to

distribute votes on the same basis among two or more nominees, as he or she sees
fit. If voting for the election of Directors is cumulative, the persons named in
the enclosed proxy will vote the shares represented thereby and by other proxies
held by them so as to elect as many of the five nominees named below as
possible. Under Ohio law and the Company's Amended and Restated Articles of
Incorporation, as amended (the "Articles of Incorporation"), broker non-votes
will not be counted in favor of any nominee and, therefore, will not affect
election results. The five nominees receiving the greatest number of votes will
be elected Directors.

Listed below are the names of those persons nominated for election as
Directors of the Company (each is currently a Director of the Company), and of
the Directors of the Company whose terms of office will continue after the
Annual Meeting, their ages, principal occupations, occupations held during the
past five years, other public companies of which they are directors (which are
shown parenthetically), the year in which they first became a Director of the
Company and the year in which their term as a Director is scheduled to expire
(information provided as of September 9, 2002):

NOMINEES FOR ELECTION AT THE ANNUAL MEETING

NAME AGE PRINCIPAL OCCUPATION/ PAST EXPERIENCE DIRECTOR TERM
---- --- ------------------------------------- SINCE EXPIRES
----- -------

J. Michael Losh......... 56 Retired Chairman of Metaldyne Corporation, 1996 2002
a manufacturer of components primarily for
the automotive industry, October 2000 to
April 2002; Chief Financial Officer of
General Motors Corporation, 1994 to
September 2000 (Metaldyne Corporation, H.B.
Fuller Company).

John B. McCoy........... 59 Chairman of the Board of Corillian 1987 2002
Corporation, a provider of internet-related
financial services, June 2000 to present; Chief
Executive Officer of Bank One Corporation, 1984
to December 1999 (Corillian Corporation, Federal
Home Loan Mortgage Corporation, SBC
Communications, Inc.).

Michael D. O'Halleran... 51 President and Chief Operating Officer of 1999 2002
Aon Corporation, an insurance brokerage,
consulting and underwriting company (Aon
Corporation).

Jean G. Spaulding, M.D. 55 Trustee of The Duke Endowment, January 2002 May 2002 2002
to present; Private practice in psychiatry
for children, adolescents and adults, 1977
to present; Associate Clinical
Professorships with both the Department of
Psychiatry and the Department of Community
& Family Medicine at Duke University
Medical Center, 1998 to present; On-camera
consultant at WTVD Newschannel 11, 1997 to
present; Vice Chancellor for Health
Affairs, Duke University Medical Center and
Health System, 1998 to 2002.

Matthew D. Walter....... 33 Chief Executive Officer of Bound Tree May 2002 2002
Medical, LLC, a provider of medical
equipment and supplies to the emergency
medical market, November 2000 to present;
Founding and Managing Partner of Talisman
Capital, a private investment company, June
2000 to present; Vice President and General
Manager of National PharmPak, Inc., a
subsidiary of Cardinal Health, Inc., July
1996 to September 2000 (Bancinsurance
Corporation). Mr. M. Walter is the son of
Robert D. Walter, Chairman and Chief
Executive Officer of the Company.

DIRECTORS WHOSE TERMS WILL CONTINUE AFTER THE ANNUAL MEETING

NAME AGE PRINCIPAL OCCUPATION/PAST EXPERIENCE DIRECTOR TERM
---- --- ------------------------------------ SINCE EXPIRES
----- -------

Dave Bing.............. 58 Chairman and Chief Executive Officer of The 2000 2003
Bing Group, L.L.C., an automotive and
industrial parts supplier and service
provider (DTE Energy Company, Steelcase
Inc.).

John F. Finn............ 54 Chairman and Chief Executive Officer of 1994 2003
Gardner, Inc., an outdoor power equipment
distributor.

John F. Havens.......... 75 Director Emeritus and retired Chairman of 1979 2003
Bank One Corporation, a bank holding company.

David W. Raisbeck....... 52 Vice Chairman of Cargill, Incorporated, an May 2002 2003
international marketer, processor and distributor
of agricultural, food, financial and industrial
products and services (Eastman Chemical Company).

Robert D. Walter....... 57 Chairman and Chief Executive Officer of the 1971 2003
Company (Viacom, Inc., American Express
Company). (1)

William E. Bindley..... 61 Chairman of Priority Healthcare Corporation, 2001 2004
a specialty pharmacy and biotech
pharmaceutical distributor; Chairman of
Bindley Capital Partners, LLC, a private
equity limited liability company; Chairman,
President and Chief Executive Officer of
Bindley Western Industries, Inc., June 1968
to February 2001 (Priority Healthcare
Corporation, Shoe Carnival, Inc.).

George H. Conrades..... 63 Chairman and Chief Executive Officer of 1999 2004
Akamai Technologies, Inc., a provider of
global internet services, April 2000 to present;
Partner in Polaris Venture Partners, August 1998
to present; Executive Vice President of GTE
Corp., May 1997 to July 1998; Chairman and Chief
Executive Officer of BBN Corporation, January 1994
to May 1997 (Akamai Technologies, Inc., Viacom
Inc., Harley-Davidson, Inc.).

Robert L. Gerbig....... 57 Retired Chairman and Chief Executive Officer 1975 2004
of Gerbig, Snell/Weisheimer & Associates,
Inc., an advertising agency.

Richard C. Notebaert.. 55 Chairman and Chief Executive Officer of 1999 2004
Qwest Communications International, Inc., a
telecommunication systems company, July 2002
to present; President and Chief Executive
Officer of Tellabs, Inc., September 2000 to
July 2002; Chairman and Chief Executive
Officer of Ameritech Corporation, April 1994
to December 1999 (Aon Corporation, Qwest
Communications International, Inc.).

---------------------------------------------

(1) Mr. R. Walter is an officer and director of various subsidiaries of the
Company.

Four regular meetings and one special meeting of the Company's Board of
Directors were held during FY02. Each Director attended 75% or more of the
meetings of the Board and Board committees on which he or she served.

Messrs. Finn, Losh, McCoy and R. Walter are the current members of the
Board's Executive Committee, which is empowered to exercise all powers and
perform all duties of the Board of Directors when the Board is not in session
other than the authority to fill vacancies among the Directors or in any
committee of the Board. The Executive Committee did not meet during the last
fiscal year, but acted one time by written action without a meeting as permitted
by Ohio law.

Messrs. Finn, Bing, Conrades, Gerbig, O'Halleran and Raisbeck are the
current members of the Board's Audit Committee, which is empowered to exercise
all powers and authority of the Board of Directors with respect to the Company's
annual audit, accounting policies, financial reporting and internal controls.
The Audit Committee met seven times during the last fiscal year.

Messrs. Losh, McCoy, Notebaert, M. Walter and Dr. Spaulding are the
current members of the Board's Human Resources and Compensation Committee (the
"Compensation Committee"), which is empowered to exercise all powers and
authority of the Board of Directors with respect to compensation of the
employees of the Company, sales to employees of stock in the Company, and grants
of stock-based incentives to employees, including options to purchase Common
Shares. The Compensation Committee met five times during the last fiscal year
and, as permitted by Ohio law, acted several times by written action without a
meeting. Messrs. Losh, McCoy, Notebaert and Dr. Spaulding are current members of
the Board's Human Resources and Compensation Subcommittee (the "Compensation
Subcommittee") which was formed to act on matters relating to and affected by
Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), Section 162(m) ("Section 162(m)") of the Internal Revenue Code of 1986,
as amended (the "Internal Revenue Code"), and all matters relating to the Chief
Executive Officer's compensation.

Messrs. McCoy, Bindley, Finn, Havens and Losh are the current members of
the Board's Nominating Committee, which is empowered to exercise all powers and
authority of the Board of Directors with respect to selection of nominees to
serve on the Board and its various committees. The Nominating Committee will
consider nominees recommended by shareholders upon submission in writing to the
Secretary of the Company of the names of such nominees, together with their
qualifications for service as a Director of the Company. The Nominating
Committee met four times during the last fiscal year.

Mr. Melburn G. Whitmire served on the Board until his retirement from
the Board on August 8, 2002. Prior to his retirement, Mr. Whitmire was a member
of the Compensation Committee.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

A property which includes parts of the Company's former Columbus food
distribution center is leased by the Company from a limited partnership in which
the general partner is Mr. R. Walter and the limited partners include Mr. R.
Walter. The Company has subleased this property to a third party at rentals
substantially in excess of the rentals it is required to pay to the limited
partnership. The lease will expire in February, 2004, and the Company has
options to renew it for two additional terms through 2024. The rent payable by
the Company currently is $92,000 per annum. If the lease is renewed, the rent
payable by the Company will increase to fair market value.

The Company owns a 31% equity interest in ArcLight Systems, LLC
("ArcLight"). In April 2002, ArcLight subleased office space from inChord
Communications, Inc. ("inChord") for a term expiring on June 30, 2008. Mr. M.
Walter is a director and minority shareholder of inChord, and his two brothers
own the remainder of inChord. During the term of this sublease, ArcLight will
pay base rent to inChord which fluctuates from $118,250 to $198,710 per year.

inChord and its subsidiaries also perform health care marketing services
on behalf of the Company and its subsidiaries from time to time in the ordinary
course of business and on arm's-length terms. During FY02, the Company paid
inChord approximately $645,600 for time and services rendered on the Company's
behalf, which amount represented less than 1% of inChord's consolidated gross
revenues for its last full fiscal year.

Mr. M. Walter and his two brothers own a majority of Bound Tree Medical,
LLC ("BTM"), an Ohio limited liability company engaged in the emergency medical
supply business. Mr. M. Walter is also an officer and manager of BTM. During
FY02, BTM and its subsidiaries purchased approximately $646,800 of product from
the Company and its subsidiaries in the ordinary course of business and on
arm's-length terms. This amount represented less than 2% of BTM's consolidated
gross revenues for its last full fiscal year.

Mr. Bindley is the chairman and beneficial owner of approximately 13.5%
of Priority Healthcare Corporation ("PHC"), a specialty pharmacy and biotech
pharmaceutical distributor. During FY02, PHC purchased products in the amount of
approximately $96 million from the Company and its subsidiaries in the ordinary
course of business and on terms which were as favorable to the Company as it
could obtain from an unrelated third party. This amount represented
approximately 11% of PHC's net sales for its last full fiscal year.

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

All executive officers and Directors of the Company timely filed all
reports required under Section 16(a) of the Exchange Act during FY02.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT

The following table sets forth certain information regarding the
beneficial ownership of the Company's Common Shares as of September 9, 2002, by:
(a) the Company's Directors; (b) each other person who is known by the Company
to own beneficially more than 5% of the outstanding Common Shares; (c) the
Company's Chief Executive Officer and the other executive officers named in the
Summary Compensation Table; and (d) the Company's executive officers and
Directors as a group. Except as otherwise described in the notes below, the
following beneficial owners have sole voting power and sole investment power
with respect to all Common Shares set forth opposite their names:

Number of
Common Shares
Name of Beneficial Owner Beneficially Owned Percent of Class
------------------------ ------------------ ----------------

FMR Corp. (1) 63,661,076 14.3%
AXA Financial, Inc. (2) 55,171,150 12.4%
Robert D. Walter (3) (4) (13) 6,485,958 1.5%
William E. Bindley (5) (6) 3,592,154 *
Matthew D. Walter (6) (12) 1,495,014 *
George L. Fotiades (4) 393,160 *
James F. Millar (4) (13) 382,535 *
John B. McCoy (6) (7) (11) 124,726 *
Stephen S. Thomas (4) (13) 118,136 *
Robert L. Gerbig (6) 80,875 *
Anthony J. Rucci (4) 63,315 *
John F. Havens (6) (8) 59,247 *
John F. Finn (6) (9) (11) 50,817 *
Richard C. Notebaert (6) (11) 26,900 *
J. Michael Losh (6) (10) (11) 24,546 *
Michael D. O'Halleran (6) 17,440 *
Dave Bing (6) (11) 15,115 *
George H. Conrades (6) (11) 13,153 *
David W. Raisbeck (6) (11) 3,870 *
Jean G. Spaulding (6) (11) 3,784 *

All Executive Officers and Directors as a 13,780,423 3.1%
Group (14) (25 Persons)

* Indicates beneficial ownership of less than 1% of the outstanding Common
Shares.

(1) Based on information obtained from a Schedule 13G filed by FMR Corp.
with the Securities and Exchange Commission on or about February 13,
2002. The address of FMR Corp. is 82 Devonshire Street, Boston,
Massachusetts 02109. FMR Corp. has sole voting power with respect to
2,106,229 Common Shares and sole dispositive power with respect to all
Common Shares held. The number of shares held by FMR Corp. may have
changed since the filing of the Schedule 13G.

(2) Based on information obtained from a Schedule 13G filed by AXA
Financial, Inc. with the Securities and Exchange Commission on or about
February 12, 2002. The address of AXA Financial, Inc. is 1290 Avenue of
the Americas, New York, New York 10104. AXA Financial, Inc. has sole
voting power with respect to 23,208,346 Common Shares and sole
dispositive power with respect to 55,008,219 Common Shares held. The
number of shares held by AXA Financial, Inc. may have changed since the
filing of the Schedule 13G.

(3) Includes 1,500,000 Common Shares held in Mr. R. Walter's grantor
retained annuity trust.

(4) Common Shares and the percent of class listed as being beneficially
owned by the Company's named executive officers include outstanding
options to purchase Common Shares which are exercisable within 60 days
of September 9, 2002, as follows: Mr. R. Walter - 1,988,761 shares; Mr.
Millar - 302,442 shares; Mr. Fotiades - 350,435 shares; Mr. Rucci -
25,500 shares; Mr. Thomas - 85,689 shares.

(5) Includes 521,827 Common Shares held in Mr. Bindley's grantor retained
annuity trust, 31,672 Common Shares held in Mr. Bindley's charitable
remainder trust, 75,000 Common Shares held in Mr. Bindley's 7- Year WEB
Charitable Remainder Trust, 63,431 Common Shares held in Mr. Bindley's
account under the Profit Sharing Plan of Bindley Western Industries,
Inc. & Subsidiaries and 6,685 Common Shares held by Mr. Bindley's wife.

(6) Common Shares and the percent of class listed as being beneficially
owned by the listed Company Directors (except for Mr. R. Walter) include
outstanding options to purchase Common Shares which are exercisable
within 60 days of September 9, 2002, as follows: Mr. Bindley - 587,512
shares; Mr. Bing - 13,562 shares; Mr. Conrades - 11,629 shares; Mr. Finn
- 27,424 shares; Mr. Gerbig - 17,753 shares; Mr. Havens - 31,542 shares;
Mr. Losh - 17,833 shares; Mr. McCoy - 31,542 shares; Mr. Notebaert -
11,629 shares; Mr. O'Halleran - 9,940 shares; Mr. Raisbeck - 3,565
shares; Dr. Spaulding - 3,556 shares; Mr. M. Walter - 3,556 shares.

(7) Includes 6,436 Common Shares held in trust for the benefit of Mr.
McCoy's son, and 50,773 Common Shares held in Mr. McCoy's grantor
retained annuity trust.

(8) Includes 26,034 Common Shares held in trust for the benefit of Mr.
Havens' spouse and children.

(9) Includes 1,032 Common Shares held by Mr. Finn's wife.

(10) Includes 1,500 Common Shares held in trust for the benefit of Mr. Losh's
daughters.

(11) Includes Common Shares held under the Company's Directors Deferred
Compensation Plan as follows: Mr. Bing - 1,553 shares; Mr. Conrades -
524 shares; Mr. Finn - 1,917 shares; Mr. Havens - 1,671 shares; Mr. Losh
- 1,838 shares; Mr. McCoy - 1,838 shares; Mr. Notebaert - 1,671 shares;
Mr. Raisbeck - 305 shares; Dr. Spaulding - 228 shares.

(12) Includes 81,064 Common Shares held in trust for the benefit of Mr. M.
Walter and 1,232,663 Common Shares beneficially owned by Mr. M. Walter
through a limited liability company.

(13) Common Shares and the percent of class listed as being beneficially
owned by the Company's named executive officers include Common Shares in
the Employee Stock Purchase Plan, as follows: Mr. Fotiades - 0 shares;
Mr. Millar - 1,078 shares; Mr. Rucci - 0 shares; Mr. Thomas - 1,408
shares; Mr. R. Walter - 1,556 shares.

(14) Common Shares and percent of class listed as being beneficially owned by
all executive officers and Directors as a group include outstanding
options to purchase Common Shares which are exercisable within 60 days
of September 9, 2002.

EXECUTIVE COMPENSATION

HUMAN RESOURCES AND COMPENSATION COMMITTEE AND SUBCOMMITTEE REPORT

The Company's executive compensation program is administered by the
Human Resources and Compensation Committee (the "Compensation Committee") of the
Company's Board of Directors, which has responsibility for reviewing all aspects
of the compensation program for the Company's executive officers. The
Compensation Committee is comprised of Messrs. Losh, McCoy, Notebaert, M. Walter
and Dr. Spaulding. The Human Resources and Compensation Subcommittee (the
"Compensation Subcommittee"), which is comprised of Messrs. Losh, McCoy,
Notebaert and Dr. Spaulding acts upon matters relating to or affected by Section
16 of the Exchange Act, Section 162(m) of the Internal Revenue Code and all
matters relating to the Chief Executive Officer's compensation. Because Mr. M.
Walter is not a member of the Compensation Subcommittee, he does not act upon
matters related to the compensation of Mr. R. Walter. The Compensation
Committee's primary objective with respect to executive compensation is to
establish programs which attract and retain key executives and align their
compensation with the Company's overall business strategies, values and
performance. To this end, the Compensation Committee has established, and the
Board of Directors has endorsed, an executive compensation philosophy which
includes the following considerations:

- A "pay-for-performance" orientation that differentiates compensation
results based upon corporate, business unit and individual
performance;

- An emphasis on long-term incentives as a significant component of
total compensation in order to more closely align the interests of
Company executives with the stock interests of shareholders;

- An objective of having an emphasis on total compensation vs. cash
compensation, rewarding Company executives with total compensation
(including cash and stock incentive programs) at or above competitive
levels, if performance is superior;

- Recognition that as an executive's level of responsibility increases,
a greater portion of the total compensation opportunity should be
based upon stock and other performance incentives; and

- An appropriate mix of short-term and long-term compensation which
facilitates retention of talented executives and encourages Company
stock ownership and capital accumulation.

The primary components of the Company's executive compensation program
are (a) base salaries, (b) annual cash incentive opportunities and (c) long-term
incentive opportunities in the form of stock options, restricted shares and
restricted share units. This three-part approach enables the Company to meet the
requirements of the highly competitive environment in which the Company operates
while ensuring that executive officers are compensated in a way that advances
both the short- and long-term interests of shareholders. Each primary component
of executive pay is discussed below.

The executive officers' and CEO's base salary, annual bonus target and
award, and long-term incentives are reviewed at least annually to ensure market
competitiveness and to assure satisfaction of the Company's objective of
providing total executive pay which achieves the appropriate leverage of
variable pay for performance and at-risk equity holdings. The Compensation
Committee and Compensation Subcommittee have been advised by independent outside
executive compensation consultants in their review of the executive officers'
and Mr. R. Walter's compensation. In making their recommendations, the
independent advisors considered the appropriate peer group of companies for the
Company. The companies considered by the independent advisors include some of,
but are not the same as, those in the Value Line Health Care Index utilized in
the Shareholder Performance Graph set forth below, and which represent a broader
spectrum of wholesale, retail and manufacturing companies that the Compensation
Committee and Compensation Subcommittee believe to be a more representative
measure of the size, scope, performance and complexity of the market for
competitive executive talent.

In reviewing compensation of the Company's executive officers for
FY02 (including that of Mr. R. Walter), the Compensation Committee and
Compensation Subcommittee considered multiple factors, including the Company's
strong performance in difficult economic conditions, size and complexity,
overall quality of earnings performance, balance sheet and cash flow
performance, expansive foreign operations and total shareholder return. The
Compensation Committee and Compensation Subcommittee also considered each
executive officer's contribution toward positioning of the Company for future
expansion and success. In addition, in establishing Mr. R. Walter's compensation
for FY02, the Compensation Subcommittee considered the growth and expansion of
the Company's business from previous years, successful integration of previously
acquired businesses, strategic positioning and continued business development
activities, more diversified lines of business, geographically diverse work
force and the Company's growth in comparison to other S&P 500 companies. The
Compensation Committee and Compensation Subcommittee observed that FY02 marked
yet another record year financially for the Company.

Base Salaries. Base salaries for Company executives are generally
subject to annual review and adjustment on the basis of individual and Company
performance, level of responsibility, and competitive, inflationary and internal
equity considerations. In order to effectively recruit and retain key managers,
the Company has adopted a base salary philosophy which takes into account
competitive market compensation levels. In considering Mr. R. Walter's FY02 base
salary, the Compensation Subcommittee considered the same factors as those
considered for other executive officers.

Annual Cash Incentives. Company executives are eligible to receive
annual cash incentive awards pursuant to the Company's Management Incentive Plan
("MIP"). Targeted MIP incentive amounts, which are designed to provide
competitive incentive pay, are established each year, with such amounts varying
as a percentage of base salary depending upon each executive's level of
responsibility and function. Performance objectives intended to focus attention
on achieving key goals are established for the Company and for each significant
business unit within the Company at the beginning of each fiscal year. These
objectives include a specific target for Company earnings growth, which target
was met for FY02. In addition, individual performance objectives are established
for each executive, which include both specific performance goals and other,
more qualitative and developmental criteria. For FY02 for managers with primary
staff or corporate responsibilities, 60% of the MIP amount was weighted to
achievement of the Company's corporate performance objectives and 40% to
achievement of individual performance objectives. For FY02 for managers with
primary operating unit responsibilities, 70% of the MIP amount was weighted to
performance of the relevant business unit, and 30% to achievement of individual
performance objectives. Incentive awards pursuant to the Company's MIP were
approved by the Compensation Committee based upon these corporate, business unit
and individual performance criteria. For FY02, the Compensation Committee also
had the discretion to grant over-achievement dollars based on individual
performance for eligible employees, including executives. These over-achievement
dollars, which are designed to reward exceptional individual performance, may
not exceed an additional 50% of an employee's MIP target amount, provided 100%
of the Company performance objectives have been achieved.

Certain executive officers' bonuses are not paid in accordance with the
MIP. Instead, their bonus is paid under the Cardinal Health, Inc.
Performance-Based Incentive Compensation Plan (the "Performance-Based Plan").
The Budget Reconciliation Act of 1993 (the "Act") amended the Internal Revenue
Code to add Section 162(m), which prohibits a deduction to any publicly held
corporation for non-performance-based compensation paid to a "covered employee"
in excess of $1 million per year (the "Dollar Limitation"). A covered employee
is an employee who, on the last day of the Company's taxable year, is the chief
executive officer of the Company or an employee who appears in the Summary
Compensation Table by reason of being one of the four most highly compensated
executive officers for the taxable year (other than the chief executive
officer). In anticipation that the deductibility of compensation paid to Mr. R.
Walter and other executive officers could be affected by the Act, in August
1996, the Company's Board of Directors adopted the Performance-Based Plan, the
material terms of the performance goals of which have been approved by the
Company's shareholders. Compensation paid in accordance with the
Performance-Based Plan generally will not be applied toward the Dollar
Limitation. Messrs. R. Walter, Millar, Fotiades, Rucci and Thomas were the
covered employees for the Company's FY02. Under the terms of the
Performance-Based Plan, and in accordance with Section 162(m), a maximum bonus
potential level is set for each covered employee if the performance goals
established by the Compensation Subcommittee are fully satisfied. The
performance goals established by the Compensation Subcommittee under the
Performance-Based Plan for the covered employees for FY02 were fully satisfied.
As permitted by the Performance-Based Plan, the Compensation Subcommittee then
considered other factors, including, without limitation, the results of the
business unit managed by each such executive, in determining the amount of bonus
paid to each covered employee for FY02, within the maximum award limits.

Long-Term Stock Incentives. The Company has granted equity-based awards
to its executives under the Company's Stock Incentive Plan (the "Stock Incentive
Plan"), which was initially approved by the Company's shareholders in 1987, and
the Company's Amended and Restated Equity Incentive Plan, as amended (the
"Equity Incentive Plan"), which replaced the Stock Incentive Plan as to ongoing
grants, and which was approved by the Company's shareholders in November 1995,
and amendments to which were approved by the Company's shareholders in November
1998. The Stock Incentive Plan was, and Equity Incentive Plan is, designed to
align a significant portion of the executive compensation package with the
long-term interests of the Company's shareholders by providing an incentive that
focuses attention on managing the Company from the perspective of an owner with
an equity stake in the business. The Equity Incentive Plan provides for the
grant of several types of equity-based awards, including stock options,
restricted shares and restricted share units.

Although not required to do so, the Company has consistently made annual
grants of stock options to its management personnel, including its executive
officers. This annual grant program is designed to provide Company managers,
over a number of years, multiple stock options, each granted with an exercise
price equal to the market

price for Common Shares on the date of the grant. Individual option grants are
determined by the Compensation Committee or Compensation Subcommittee based on a
manager's current performance, potential for future responsibility, and salary
multiples designed to increase the portion of the total compensation opportunity
represented by stock incentives as a manager's level of responsibility
increases. Because a primary purpose of granting stock options is to encourage
positive future performance, when granting options in FY02 the Compensation
Committee and Compensation Subcommittee did not consider the number of options
granted to an individual in previous years. The Company's standard stock option
agreement contains provisions providing for forfeiture of the option or option
value received in the event the option holder engages in certain behavior in
competition with or contrary to the interests of the Company. The Compensation
Committee and Compensation Subcommittee place a relatively heavy emphasis on
stock options, consistent with its philosophy that stock incentives more closely
align the interests of Company managers with the long-term interests of
shareholders.

Approximately 3,300 individuals below the executive officer level were
granted stock options under the Company's Equity Incentive Plan and
Broadly-based Equity Incentive Plan during FY02. This program is an increasingly
important element of the Company's efforts to identify, develop and motivate key
employees who will sustain the Company's superior performance in the future. It
also reinforces an entrepreneurial environment by providing real incentives for
these employees to sustain and enhance the Company's long-term performance.

Grants of restricted shares and restricted share units are intended to
reward exceptional performance with a long-term benefit in lieu of cash, to
facilitate stock ownership and to deter recruitment of key Company managers by
competitors and others. Unlike the Company's stock option program, restricted
share and restricted share unit grants are not made on an annual or other
regularly established basis. Recipients of restricted share and restricted share
unit grants are subject to restrictions on the disposition of the stock during a
period determined by the Compensation Committee or Compensation Subcommittee at
the time of grant. Generally, restricted share and restricted share unit awards
are forfeited by their terms if the recipient terminates employment with the
Company prior to the expiration of the restriction period. Restricted share and
restricted share unit awards are, in most instances, also forfeited by their
terms if the recipient engages in certain behavior in competition with or
contrary to the interests of the Company.

Consistent with the Company's philosophy of linking total compensation
to stock performance for all of its executive officers, a significant portion of
Mr. R. Walter's overall compensation package is comprised of stock incentives.
In November 2001, the Compensation Subcommittee granted Mr. R. Walter options to
purchase 440,529 Common Shares with an exercise price of $68.10 per share (the
market price on the date of grant) as part of the annual option grant made to
Company executives. Consistent with the other options granted as part of the
annual grant, these options vest on the third anniversary of the grant date and
have a term of ten years. In making this grant, the Compensation Subcommittee
considered several of the same factors as those considered for the other
executive officers, including implementation of the Compensation Subcommittee's
objective to more closely align the Company's stock incentive awards with those
of the market. In addition, the Compensation Subcommittee took into account Mr.
R. Walter's leadership effectiveness, as well as the Company's consistent,
multi-year financial performance, its strong strategic positioning, and the
overall market competitiveness of Mr. R. Walter's total compensation package.
All of the options granted to Mr. R. Walter during the fiscal year also contain
provisions for forfeiture of the option or option value received in the event
Mr. R. Walter engages in certain behavior in competition with or contrary to the
interests of the Company. In connection with the Walter Agreement (discussed
below under "Employment Agreements and Other Arrangements"), Mr. R. Walter also
received 150,000 restricted share units during the fiscal year, reflecting the
Compensation Subcommittee's intent to provide management continuity. The
restricted share units will vest on June 30, 2004 so long as Mr. R. Walter is
employed by the Company through that date.

Impact of Internal Revenue Code Section 162(m). As discussed above,
Section 162(m) of the Internal Revenue Code prohibits a deduction to any
publicly held corporation for non-performance-based compensation paid to a
covered employee in excess of the Dollar Limitation. It is the Compensation
Subcommittee's general policy to minimize the effect of the Act on the Company's
compensation expense. However, as a result of the Act, a non-material amount of
compensation earned by certain covered employees was nondeductible in FY02,
primarily as a result of the vesting of restricted shares granted in prior
years. The Compensation Subcommittee reserves the authority to award
non-deductible compensation in such circumstances as it deems appropriate.
Further, because of

ambiguities and uncertainties as to the application and interpretation of
Section 162(m) and the regulations issued thereunder, no assurance can be given,
notwithstanding the Company's efforts, that compensation intended by the Company
to satisfy the requirements for deductibility under Section 162(m) does in fact
do so.

Conclusion. As described above, the Company's executive compensation
program provides a significant link between total compensation and the Company's
performance and long-term shareholder value consistent with the compensation
philosophies set forth above. This program is believed to be a significant
factor in the Company's growth and profitability and the resulting long-term
gains achieved by the Company's shareholders.

Submitted by the Human Resources and Compensation Committee and Subcommittee of
the Board:

August 6, 2002
J. Michael Losh, Chairman Subcommittee:
John B. McCoy J. Michael Losh
Richard C. Notebaert John B. McCoy
Jean G. Spaulding Richard C. Notebaert
Matthew D. Walter Jean G. Spaulding

The preceding Human Resources and Compensation Committee and Subcommittee Report
and the Performance Graph included elsewhere in this Proxy Statement do not
constitute soliciting material and should not be deemed filed or incorporated by
reference into any other Company filing under the Securities Act of 1933, as
amended (the "Securities Act"), or the Exchange Act, except to the extent the
Company specifically incorporates this Report or the Performance Graph by
reference in such filing.

EXECUTIVE COMPENSATION

The following information is set forth with respect to the Company's
Chief Executive Officer and each of the Company's four other most highly
compensated executive officers.

I. SUMMARY COMPENSATION TABLE

------------------------------------------------------------------------------------------------------------------
ANNUAL COMPENSATION LONG-TERM COMPENSATION
AWARDS
------------------------------------------------------------------------------------------------------------------
OTHER RESTRICTED SECURITIES ALL
NAME AND FY - SALARY BONUS ANNUAL STOCK UNDERLYING OTHER
PRINCIPAL POSITION ENDED ($) ($) COMPENSATION AWARDS OPTIONS COMPENSATION
($)(1) ($)(2)(3) (#)(3) ($)(4)
-----------------------------------------------------------------------------------------------------------------

Robert D. Walter 2002 $1,000,000 $2,701,370 $173,545(5) $10,354,500(7) 440,529 $ 208,938(6)
Chairman & Chief 2001 968,847 1,828,493 139,729 -0- 272,384 213,585
Executive Officer 2000 949,231 1,836,517 64,835 -0- 1,425,000 206,924
------------------------------------------------------------------------------------------------------
James F. Millar 2002 $ 634,491 $ 807,393 - -0- 100,955 $1,003,479(8)
Executive Vice 2001 590,385 702,894 - -0- 94,578 32,450
President; 2000 479,019 565,331 - $ 971,250(7) 112,941 31,289
President & Chief
Operating Officer
- Pharmaceutical
Distribution and
Medical Products
--------------------------------------------------------------------------------------------------------

Table continued on next page.

George L. Fotiades 2002 $495,692 $498,482 - -0- 67,915 $1,052,667(8)(9)
Executive Vice 2001 491,410 340,360 - -0- 60,530 67,167
President; 2000 446,167 529,095 - $ 878,750(7) 67,907 94,289
President & Chief
Operating Officer
- Pharmaceutical
Technologies and
Services
-----------------------------------------------------------------------------------------------------------------
Anthony J. Rucci 2002 $416,219 $398,263 - -0- 48,164 $ 383,729(8)
Executive Vice 2001 399,616 339,558 - -0- 46,532 128,450
President & Chief 2000 241,423 240,284 - $1,022,740(7) 89,511 66,726
Administrative
Officer (9)
-----------------------------------------------------------------------------------------------------------------
Stephen S. Thomas 2002 $380,694 $372,003 - -0- 38,546 $ 698,229(8)
Executive Vice 2001 366,173 230,318 - -0- 33,776 32,450
President; Group 2000 348,245 129,378 - $1,165,985(7) 39,535 31,289
President -
Automation &
Information
Services
-----------------------------------------------------------------------------------------------------------------

(1) "-" indicates that the aggregate amount of perquisites and other personal
benefits, securities or property in the aggregate did not exceed the lesser
of $50,000 or 10% of the total of Salary and Bonus, and the executive had
no other compensation reportable under this category.

(2) Aggregate restricted share holdings and values on June 28, 2002 (based upon
the closing price of the Common Shares on the New York Stock Exchange on
that date, the last trading day of FY02), for the named executive officers
are as follows: (i) Mr. R. Walter - 264,644 shares, $16,251,788, (ii) Mr.
Millar - 29,137 shares, $1,789,303, (iii) Mr. Fotiades - 26,362 shares,
$1,618,890; (iv) Mr. Rucci - 25,620 shares, $1,573,324, and (v) Mr. Thomas
- 19,980 shares, $1,226,972. Dividends are paid on restricted shares at the
same rate as all Common Shares.

(3) All numbers have been adjusted to reflect all applicable stock splits of
the Company's Common Shares.

(4) Amounts shown represent Company contributions to the executive's account
under the Company's Profit Sharing and Retirement Savings Plan (or
applicable subsidiary 401(k) plan) and the Company's Incentive Deferred
Compensation Plan for FY02 as follows: Messrs. R. Walter, Millar, Rucci
and Thomas - $32,229 and Mr. Fotiades - $7,250.

(5) Includes $160,827, $127,323 and $51,435 and related gross-up for taxes
relating to personal use by Mr. R. Walter, his family and associates of a
Company airplane for the fiscal years ended June 30, 2002, 2001, and 2000,
respectively.

(6) Includes $150,212 for premiums paid by the Company on a split-dollar
life insurance arrangement, entered into on April 16, 1993, among the
Company, Mr. R. Walter and a trust for Mr. R. Walter's family. Upon the
earlier to occur of January 12, 2003, or the death of the survivor of
Mr. R. Walter and his spouse, the Company expects to recover, per the
terms of the arrangement, the current cash surrender value of the
underlying

insurance policy. Also includes $26,497 paid by the Company
for legal fees incurred in connection with the Walter Agreement (see
"Employment Agreements and Other Arrangements" below).

(7) Includes restricted shares or restricted share units that vest in under
three years from the date of grant as follows: (i) Mr. Walter - 150,000
shares vesting on 6/30/04; (ii) Mr. Millar - 29,137 shares which vested on
2/9/02; (iii) Mr. Fotiades - 26,362 shares which vested on 2/9/02; (iv) Mr.
Rucci - 7,425 shares which vested on 11/8/00, 7,425 shares which vested on
11/8/01, 10,545 shares which vested on 2/9/02, and 7,650 shares vesting on
11/8/02; and (v) Mr. Thomas - 19,980 shares which vested on 2/9/02.

(8) Includes the vesting of cash incentive awards, granted in the fiscal year
ended June 30, 2000, as follows: Mr. Millar - $971,250; Mr. Fotiades -
$878,750; Mr. Rucci - $351,500, and Mr. Thomas - $666,000. (See
"Employment Agreements and Other Arrangements" below.)

(9) Includes $166,667 paid to Mr. Fotiades as an incentive fee pursuant to
certain provisions contained in the Original Fotiades Agreement (as
described and defined below under "Employment Agreements and Other
Arrangements").

II. OPTION/SAR GRANTS IN LAST FISCAL YEAR (1)

-----------------------------------------------------------------------------------------------------------------
INDIVIDUAL GRANTS
--------------------------------------------------------------------------
PERCENT OF
NUMBER OF TOTAL POTENTIAL REALIZABLE VALUE
SECURITIES OPTIONS EXERCISE AT ASSUMED ANNUAL RATES
NAME UNDERLYING GRANTED TO PRICE EXPIRATION OF STOCK PRICE APPRECIATION
OPTIONS EMPLOYEES ($/SH)(3) DATE FOR OPTION TERM (4)
GRANTED IN FISCAL
(#)($) YEAR(2) 0%($) 5%($) 10%($)
--------------------------------------------------------------------------------------------------------------

Robert D. Walter 440,529 5.4% $68.10 11/19/11 $0.00 $18,866,855 $47,812,314
--------------------------------------------------------------------------------------------------------------

--------------------------------------------------------------------------------------------------------------
James F. Millar 100,955 1.2% $68.10 11/19/11 $0.00 $4,323,673 $10,957,036
--------------------------------------------------------------------------------------------------------------

--------------------------------------------------------------------------------------------------------------
George L. Fotiades 67,915 0.83% $68.10 11/19/11 $0.00 $2,908,645 $7,371,077
--------------------------------------------------------------------------------------------------------------

--------------------------------------------------------------------------------------------------------------
Anthony J. Rucci 48,164 0.59% $68.10 11/19/11 $0.00 $2,062,755 $5,227,425
--------------------------------------------------------------------------------------------------------------

--------------------------------------------------------------------------------------------------------------
Stephen S. Thomas 38,546 0.47% $68.10 11/19/11 $0.00 $1,650,837 $4,183,546
--------------------------------------------------------------------------------------------------------------

(1) All options granted during the fiscal year to the named executives are
nonqualified stock options and are exercisable on and after the third
anniversary from the date of grant.

(2) Based on 8,142,675 options granted to all employees during FY02 under the
Company's Equity Incentive Plan and Broadly-based Equity Incentive Plan.

(3) Market price on date of grant.

(4) These amounts are based on hypothetical appreciation rates of 0%, 5% and 10%
and are not intended to forecast the actual future appreciation of the
Company's stock price. No gain to optionees is possible without an actual
increase in the price of the Company's Common Shares, which increase
benefits all of the Company's shareholders.

III. AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR
AND FY-END OPTION VALUES

----------------------------------------------------------------------------------------------------
NUMBER OF VALUE OF
UNEXERCISED UNEXERCISED
OPTIONS IN-THE-MONEY
AT FY-END OPTIONS
(#) AT FY-END ($)(2)
------------------ -----------------------
SHARES VALUE
ACQUIRED ON REALIZED EXERCISABLE/ EXERCISABLE/
NAME EXERCISE (#) ($)(1) UNEXERCISABLE UNEXERCISABLE
---------------------------------------------------------------------------------------------------

Robert D. Walter 58,220 $3,483,894 1,979,761/1,197,413 $63,832,459/$14,652,734
---------------------------------------------------------------------------------------------------
James F. Millar 15,611 $ 926,985 286,831/308,474 $10,491,305/$3,415,675
---------------------------------------------------------------------------------------------------
George L. Fotiades 44,144 $1,907,454 306,291/196,352 $8,338,690/$2,053,711
---------------------------------------------------------------------------------------------------
Anthony J. Rucci -0- -0- 0/184,207 $0/$2,741,098
---------------------------------------------------------------------------------------------------
Stephen S. Thomas -0- -0- 85,689/131,625 $2,062,706/$1,793,501
---------------------------------------------------------------------------------------------------

(1) Value calculated as the difference between the fair market value of the
Common Shares on the date of exercise and the option exercise price before
payment of any taxes.

(2) Value calculated as the difference between the fair market value of the
Common Shares on June 28, 2002 (the last trading day of FY02) and the option
exercise price.

SHAREHOLDER PERFORMANCE GRAPH

Set forth below is a line graph comparing the cumulative total return of
the Company's Common Shares with the cumulative total return of the Standard &
Poor's Composite - 500 Stock Index and the Value Line Health Care Sector Index,
an independently prepared index which includes more than 100 companies in the
health care industry (the "Value Line Health Care Index" or "Peer Group"). The
graph assumes, in each case, an initial investment of $100 as of June 30, 1997
based on the market prices at the end of each fiscal year through and including
June 30, 2002, with the Value Line Health Care Index investment weighted on the
basis of market capitalization at the beginning of each such fiscal year, and
assuming reinvestment of dividends (and taking into account all stock splits
during such periods).

----------------------------------------------------------------------------------------------
Fiscal Year 1997 1998 1999 2000 2001 2002
----------------------------------------------------------------------------------------------

Cardinal Health, Inc. $100.00 $163.98 $168.49 $194.82 $273.52 $263.74
----------------------------------------------------------------------------------------------
S&P 500 100.00 128.09 155.24 164.51 138.47 120.69
----------------------------------------------------------------------------------------------
Value Line Health Care Index 100.00 134.01 153.43 180.34 171.09 146.30
----------------------------------------------------------------------------------------------
Source: Value Line, Inc.

EMPLOYMENT AGREEMENTS AND OTHER ARRANGEMENTS

During the fiscal year ended June 30, 2002, the Company entered into an
agreement with Mr. R. Walter (the "Walter Agreement"). The Walter Agreement
provides for an employment term through June 30, 2004. However, the Walter
Agreement will extend beyond June 30, 2004 on a day-for-day basis for each day
Mr. R. Walter remains employed by the Company after June 30, 2003. Commencing
June 30, 2003, the Company or Mr. R. Walter can provide notice of termination to
be effective one year from the notice date. In addition to base salary and an
annual cash incentive payable under the standard terms of the bonus plan for
which Mr. R. Walter is eligible, the Walter Agreement provides for an annual
option grant and an initial grant of restricted share units. The Walter
Agreement also provides for a severance payment to Mr. R. Walter in the event
the Company terminates Mr. R. Walter's employment without Cause or Mr. R. Walter
terminates employment for Good Reason (each as defined in the Walter Agreement)
prior to the end of his full time employment period. The amount of such
severance payment is increased if such termination occurs within three years of
a Change of Control (as defined in the Walter Agreement) of the Company. In the
event of Mr. R. Walter's death, the Walter Agreement provides for death benefits
and payment of Accrued Obligations (as defined in the Walter Agreement). In the
event of Mr. R. Walter's Disability (as defined in the Walter Agreement), Mr. R.
Walter will receive the Company's disability benefits and Accrued Obligations.
In the event of Mr. R. Walter's death or the Company terminates Mr. R. Walter's
employment without Cause or Mr. R. Walter terminates employment for Good Reason,
all stock options, restricted shares and restricted share units (collectively,
"Stock Awards") held by Mr. R. Walter at the time of such event will vest and
stock options will remain exercisable until the end of their original term. In
the event of Mr. R. Walter's retirement prior to June 30, 2004, all Stock Awards
will continue to vest or be forfeited in accordance with their original terms.
If Mr. R. Walter becomes Disabled during the employment term or retires after
June 30, 2004, generally all Stock Awards held by

Mr. R. Walter at that time will vest in accordance with their original terms and
stock options will remain exercisable until the end of their original term.
Under the Walter Agreement, Mr. R. Walter has agreed to comply with certain
non-compete and non-solicitation covenants during the term of his employment and
generally for two years thereafter. In addition, Mr. R. Walter is obligated to
keep the Company's proprietary information and trade secrets confidential.

During the fiscal year ended June 30, 2000, the Company entered into an
agreement with Mr. Millar (the "Millar Agreement"), which replaced and
superceded the employment agreement previously in place between the Company and
Mr. Millar. The Millar Agreement provides for an employment term of three years
commencing on February 9, 2000. In addition to base salary and an annual cash
incentive payable under the standard terms of the bonus plan for which Mr.
Millar is eligible, the Millar Agreement provides for an additional incentive
award, payable one-half in cash and one-half in restricted shares, if Mr. Millar
remained employed by the Company through February 9, 2002. Inasmuch as Mr.
Millar continued to be employed by the Company on that date, the additional
incentive award vested and became payable. The Millar Agreement also provides
for a severance payment to Mr. Millar in the event the Company terminates Mr.
Millar's employment without Cause (as defined in the Millar Agreement) prior to
the end of his full time employment period. Under the Millar Agreement, Mr.
Millar has agreed to comply with certain non-compete and non-solicitation
covenants during the term of his employment and generally for twelve months
thereafter. In addition, Mr. Millar is obligated to keep the Company's
proprietary information and trade secrets confidential.

During the fiscal year ended June 30, 2000, the Company entered into an
agreement with Mr. Fotiades (the "Fotiades Agreement"), which replaced and
superceded the employment agreement previously entered into between the Company
and Mr. Fotiades at the time the Company acquired R.P. Scherer Corporation
("R.P. Scherer") (such previous agreement, the "Original Fotiades Agreement").
The Fotiades Agreement provides for an employment term of thirty-three months
commencing on February 9, 2000. In addition to base salary and an annual cash
incentive payable under the standard terms of the bonus plan for which Mr.
Fotiades is eligible, the Fotiades Agreement provides for an additional
incentive award, payable one-half in cash and one-half in restricted shares, if
Mr. Fotiades remained employed by the Company through February 9, 2002. Inasmuch
as Mr. Fotiades continued to be employed by the Company on that date, the
additional incentive award vested and became payable. The Fotiades Agreement
also provides for a severance payment to Mr. Fotiades in the event the Company
terminates Mr. Fotiades' employment without Cause or Mr. Fotiades terminates his
employment for Good Reason (each as defined in the Fotiades Agreement) prior to
the end of his full time employment period. The Original Fotiades Agreement
provided and the new Fotiades Agreement provides for a fee of $166,667 which was
paid to Mr. Fotiades on or about August 7, 2000 and August 7, 2001. Under the
Fotiades Agreement, Mr. Fotiades has agreed to comply with certain non-compete
and non-solicitation covenants during the term of his employment and generally
for twelve months thereafter. In addition, Mr. Fotiades is obligated to keep the
Company's proprietary information and trade secrets confidential.

During the fiscal year ended June 30, 2000, the Company entered into an
agreement with Mr. Rucci (the "Rucci Agreement"). In addition to base salary and
an annual cash incentive payable under the standard terms of the bonus plan for
which Mr. Rucci is eligible, the Rucci Agreement provides for an additional
incentive award, payable one-half in cash and one-half in restricted shares, if
Mr. Rucci remained employed by the Company through February 9, 2002. Inasmuch as
Mr. Rucci continued to be employed by the Company on that date, the additional
incentive award vested and became payable. The Rucci Agreement also provides for
a severance payment to Mr. Rucci in the event the Company terminated Mr. Rucci's
employment without Cause (as defined in the Rucci Agreement) prior to February
9, 2002. Inasmuch as Mr. Rucci remained employed by the Company on that date,
the severance payment did not become payable. Under the Rucci Agreement, Mr.
Rucci has agreed to comply with certain non-compete and non-solicitation
covenants during the term of his employment and generally for twelve months
thereafter. In addition, Mr. Rucci is obligated to keep the Company's
proprietary information and trade secrets confidential.

During the fiscal year ended June 30, 2000, the Company entered into an
agreement with Mr. Thomas (the "Thomas Agreement"). The Thomas Agreement
provides for an employment term of three years commencing on July 1, 1999. In
addition to base salary and an annual cash incentive payable under the standard
terms of the bonus plan for which Mr. Thomas is eligible, the Thomas Agreement
provides for an additional incentive award, payable one-half in cash and
one-half in restricted shares, if Mr. Thomas remained employed by the Company
through

February 9, 2002. Inasmuch as Mr. Thomas continued to be employed by the Company
on that date, the additional incentive award vested and became payable. The
Thomas Agreement also provides for a severance payment to Mr. Thomas in the
event the Company terminated Mr. Thomas' employment without Cause (as defined in
the Thomas Agreement) prior to February 9, 2002. Inasmuch as Mr. Thomas remained
employed by the Company on that date, the severance payment did not become
payable. The Thomas Agreement also provides for a severance payment to Mr.
Thomas in the event the Company terminates Mr. Thomas' employment without Cause
or Mr. Thomas terminates his employment for Good Reason (each as defined in the
Thomas Agreement) prior to the end of his full time employment period. Under the
Thomas Agreement, Mr. Thomas has agreed to comply with certain non-compete and
non-solicitation covenants during the term of his employment and generally for
twelve months thereafter. In addition, Mr. Thomas is obligated to keep the
Company's proprietary information and trade secrets confidential.

The Company's Stock Incentive Plan, Equity Incentive Plan and
Broadly-based Equity Incentive Plan each provides for acceleration of the
vesting of stock options, restricted share and restricted share unit awards
based upon the occurrence of a change of control of the Company. A change of
control is defined generally, with certain exclusions, as acquisition by an
individual or group of 25% or more of the Common Shares, an involuntary change
in the composition of at least a majority of the members of the Board of
Directors, or approval by the Company's shareholders (or consummation, depending
upon the date of the grant) of a merger, reorganization, consolidation,
liquidation, or sale of substantially all of the assets of the Company.

PENSION PLAN TABLE

Mr. Fotiades participates in a defined benefit and supplemental plan
(the "Pension Plan") which was assumed by the Company when the Company acquired
R.P. Scherer in 1998. Benefits payable under the Pension Plan at retirement are
determined primarily by average final compensation and years of service. The
following table sets forth estimated annual benefits payable upon retirement in
the specified compensation and years of service classification.

---------------- --------------------------------------------------------- ----------- ---------
5 YEAR AVERAGE
REMUNERATION YEARS OF SERVICE
---------------- -------------------------------------------------------------------------------
5 10 15 20 25 30 35
------------------------------------------------------------------------------------------------

$125,000 $8,475 $16,950 $25,425 $33,900 $42,375 $50,850 $59,325
------------------------------------------------------------------------------------------------
$150,000 $10,350 $20,700 $31,050 $41,400 $51,750 $62,100 $72,450
------------------------------------------------------------------------------------------------
$175,000 $12,225 $24,450 $36,675 $48,900 $61,125 $73,350 $85,575
------------------------------------------------------------------------------------------------
$200,000 $14,100 $28,200 $42,300 $56,400 $70,500 $84,600 $98,700
------------------------------------------------------------------------------------------------
$225,000 $15,975 $31,950 $47,925 $63,900 $79,875 $95,850 $111,825
------------------------------------------------------------------------------------------------
$250,000 $17,850 $35,700 $53,550 $71,400 $89,250 $107,100 $124,950
------------------------------------------------------------------------------------------------
$300,000 $19,593 $39,186 $58,779 $78,372 $97,965 $117,558 $137,152
------------------------------------------------------------------------------------------------
$400,000 $19,593 $39,186 $58,779 $78,372 $97,965 $117,558 $137,152
------------------------------------------------------------------------------------------------
$450,000 $19,593 $39,186 $58,779 $78,372 $97,965 $117,558 $137,152
------------------------------------------------------------------------------------------------
$500,000 $19,593 $39,186 $58,779 $78,372 $97,965 $117,558 $137,152
------------------------------------------------------------------------------------------------
$750,000 $19,593 $39,186 $58,779 $78,372 $97,965 $117,558 $137,152
------------------------------------------------------------------------------------------------
$1,000,000 $19,593 $39,186 $58,779 $78,372 $97,965 $117,558 $137,152
------------------------------------------------------------------------------------------------
$1,250,000 $19,593 $39,186 $58,779 $78,372 $97,965 $117,558 $137,152
------------------------------------------------------------------------------------------------

The compensation covered by the Pension Plan for Mr. Fotiades is
substantially the same as that set forth in the Salary and Bonus columns of the
Summary Compensation Table set forth on pages 11 and 12. Mr. Fotiades has
approximately 6 years of service credited under the Pension Plan. The benefits
are payable as a straight-life annuity beginning at age 65. These benefits are
not subject to any deduction for Social Security or any other offset amounts.

COMPENSATION OF DIRECTORS

During the fiscal year ended June 30, 2002, the Company's non-employee
Directors ("Outside Directors") each were paid $10,000 per fiscal quarter. An
Outside Director serving as chairperson of a Board committee received $1,000 per
quarter for such service. By unanimous approval of the Compensation Committee,
Mr. Finn received an additional fee of $5,000 in consideration of the
extraordinary demands required of him in his role as Chairperson of the Audit
Committee which resulted from the Company's transition to a new independent
auditor during FY02 (see "Information Regarding Change of Independent Auditors"
below). Other than the chairperson, Outside Directors receive no additional
compensation for service on Board committees. Outside Directors may elect to
defer payment of their fees into the Company's Directors Deferred Compensation
Plan, one of the investment alternatives for which is a Company Common Shares
Fund. The Company also reimburses Outside Directors for out-of-pocket travel
expenses incurred in connection with attendance at Board and committee meetings.
Employee Directors do not receive additional compensation in their capacity as
Directors.

Outside Directors receive an annual option grant to purchase Common
Shares having an aggregate exercise price for such Common Shares of $250,000.
Each Outside Director also receives, upon first appointment or election to the
Board, an option grant to purchase Common Shares having an aggregate exercise
price for such Common Shares of $250,000. The exercise price per share of these
options is the fair market value of a Common Share on the date of grant. The
actual value of the options will be the difference between the market value of
the underlying Common Shares on the exercise date and the exercise price. In
determining the value of the Outside Director options and, thus, the total
compensation to Outside Directors, the Board of Directors made certain
assumptions about the future increase in the market value of the Company's
Common Shares over the term of the options. The options are granted pursuant to
the Company's Equity Incentive Plan and Outside Directors Equity Incentive Plan.
All grants to Outside Directors generally vest immediately, are exercisable for
ten years from the date of grant, and are subject to adjustment for subsequent
stock dividends, splits, and other changes in the Company's capital structure.
Options granted to Outside Directors are treated as nonqualified options under
the Internal Revenue Code. On November 7, 2001, Messrs. Bindley, Bing, Conrades,
Finn, Gerbig, Havens, Losh, McCoy, Notebaert, and O'Halleran each were granted
options to purchase 3,912 Common Shares in accordance with the provisions of the
Equity Incentive Plan and the Outside Directors Equity Incentive Plan. On May 1,
2002, Dr. Spaulding and Mr. M. Walter each were granted options to purchase
3,556 Common Shares in accordance with the provisions of the Equity Incentive
Plan and the Outside Directors Equity Incentive Plan. On May 8, 2002, Mr.
Raisbeck was granted options to purchase 3,565 Commons Shares in accordance with
the provisions of the Equity Incentive Plan and the Outside Directors Equity
Incentive Plan.

AUDIT COMMITTEE REPORT

The following Audit Committee Report does not constitute soliciting material and
should not be deemed filed or incorporated by reference into any other Company
filing under the Securities Act or the Exchange Act, except to the extent the
Company specifically incorporates this Report by reference in such filing.

The Audit Committee currently consists of six members of the Company's
Board of Directors, each of whom is independent of the Company and its
management, as defined by the New York Stock Exchange listing standards. In
February 2002, the Board adopted an amended and restated charter for the Audit
Committee. The charter specifies the scope of the Audit Committee's
responsibilities and how it carries out those responsibilities. A copy of the
amended and restated charter is attached to this proxy statement as Appendix A.

The Audit Committee has reviewed and discussed the audited financial
statements for the fiscal year ended June 30, 2002 (the "FY02 Audited Financial
Statements") with Company management and with Ernst & Young LLP ("Ernst &
Young"), the Company's independent auditors. The Audit Committee also has
discussed with Ernst & Young the matters required to be discussed by Statement
on Auditing Standards No. 61 (Communication with Audit Committees), as amended
by Statement on Auditing Standards No. 90 (Audit Committee Communications). The
Audit Committee also received from Ernst & Young the written disclosures and the
letter required by Independence Standards Board Standard No. 1 (Independence
Discussions with Audit Committees) and has discussed with Ernst &

Young its independence from the Company. The Audit Committee also has considered
whether the provision of non-audit services to the Company is compatible with
the independence of Ernst & Young.

Based on the review and discussions referred to above, and relying
thereon, the Audit Committee recommended to the Board of Directors that the FY02
Audited Financial Statements be included in the Company's Annual Report on Form
10-K for the fiscal year ended June 30, 2002 filed with the Securities and
Exchange Commission.

Submitted by the Audit Committee of the Board.

August 6, 2002 John F. Finn, Chairman
Dave Bing
George H. Conrades
Robert L. Gerbig
Michael D. O'Halleran
David W. Raisbeck

SELECTION OF INDEPENDENT AUDITORS

INFORMATION REGARDING CHANGE OF INDEPENDENT ACCOUNTANTS

On May 8, 2002, the Board of Directors of the Company, upon the
recommendation of its Audit Committee, dismissed Arthur Andersen LLP ("Arthur
Andersen" or "AA") as the Company's independent public accountants and engaged
Ernst & Young to serve as the Company's independent public accountants for the
fiscal year ending June 30, 2002. Arthur Andersen's reports on the Company's
consolidated financial statements for each of the years ended June 30, 2001 and
2000 did not contain an adverse opinion or disclaimer of opinion, nor were they
qualified or modified as to uncertainty, audit scope or accounting principles.
In connection with its audits for the Company's fiscal years ended June 30, 2001
and 2000 and through May 8, 2002, there were no disagreements between the
Company and Arthur Andersen on any matter of accounting principle or practice,
financial statement disclosure, or auditing scope or procedure which, if not
resolved to AA's satisfaction, would have caused AA to make reference to the
subject matter in connection with AA's report on the Company's consolidated
financial statements for such years; and there were no reportable events as
defined in Item 304(a)(1)(v) of Securities and Exchange Commission Regulation
S-K. The Company provided Arthur Andersen with a copy of the foregoing
disclosures. Attached as Exhibit 16 to the Company's Current Report on Form 8-K
filed with the Securities and Exchange Commission on May 9, 2002 is a copy of
AA's letter, dated May 9, 2002, stating its agreement with such statements.
During the fiscal years ended June 30, 2001 and 2000 and through May 8, 2002,
the Company did not consult Ernst & Young with respect to the application of
accounting principles to a specified transaction, either completed or proposed,
or the type of audit opinion that might be rendered on the Company's
consolidated financial statements, or any other matters or reportable events
listed in Items 304(a)(2)(i) and (ii) of Regulation S-K.

INDEPENDENT ACCOUNTANT FEES

As described above, the Company changed its independent public
accountants during FY02 from Arthur Andersen to Ernst & Young. Ernst & Young was
appointed on May 9, 2002 to conduct the examination of the Company's financial
statements for FY02. The fees paid to Arthur Andersen during FY02 for audit
services totaled approximately $772,000. Fees paid to Ernst & Young for services
rendered during FY02 are summarized below, broken down between the periods
before and after Ernst & Young was appointed to be the Company's independent
public accountants. For FY02, fees for services rendered by Ernst & Young
totaled approximately $4,883,000 as described in more detail below.

AUDIT FEES

Ernst & Young billed the Company $2,307,000 for professional services
rendered in connection with the audit of the Company's financial statements for
the fiscal year ended June 30, 2002. Such services included a review

of financial statements included in the Company's Quarterly Report on Form 10-Q
for the quarter ended March 31, 2002, and statutory audits of various
international subsidiaries.

FINANCIAL INFORMATION SYSTEMS DESIGN AND IMPLEMENTATION FEES

Ernst & Young did not bill the Company any fees during the fiscal year
ended June 30, 2002 in connection with the design and implementation of
financial information systems.

ALL OTHER FEES

Ernst & Young billed the Company an aggregate of $2,576,000 in fees for
other services rendered to the Company and its subsidiaries for the fiscal year
ended June 30, 2002. Of the total amount of other fees billed to the Company,
$2,313,000 was for services rendered prior to Ernst & Young's appointment as the
Company's independent auditor on May 9, 2002, and $263,000 related to services
rendered after such appointment. The services performed by Ernst & Young
primarily related to the following:

- acquisitions and due diligence
- tax compliance and consulting
- litigation assistance
- internal audit services(1)

(1) The internal audit service arrangement existed prior to Ernst & Young's
appointment as the Company's independent auditor. During FY02 Ernst & Young
billed the Company $252,000 for professional services rendered under the
internal audit service arrangement. This arrangement with Ernst & Young was
terminated immediately upon their appointment as the Company's independent
auditor.

Representatives of Ernst & Young, which served as the Company's
certifying accountant for FY02 and which the Board has appointed as the
certifying accountant for the fiscal year ending June 30, 2003, are expected to
be present at the Annual Meeting. At the Annual Meeting representatives of Ernst
& Young will have the opportunity to make a statement about the Company's
financial condition, if they desire to do so, and to respond to appropriate
questions from shareholders.

PROPOSAL 1 - ELECTION OF NOMINEES FOR DIRECTORS OF THE COMPANY AT THE ANNUAL
MEETING

The Company's Board of Directors has nominated each of J. Michael Losh,
John B. McCoy, Michael D. O'Halleran, Jean G. Spaulding and Matthew D. Walter to
serve as a Director of the Company for a term of three years and until his or
her successor is duly elected and qualified. Each of Messrs. Losh, McCoy,
O'Halleran, M. Walter, and Dr. Spaulding currently serves as a Director of the
Company.

THE BOARD OF DIRECTORS RECOMMENDS THAT THE COMPANY'S SHAREHOLDERS VOTE FOR
THESE NOMINEES TO SERVE AS MORE FULLY DESCRIBED UNDER "ELECTION OF DIRECTORS" IN
THIS PROXY STATEMENT.

FUTURE SHAREHOLDER PROPOSALS

Any shareholder who intends to present a proposal for the Company's 2003
Annual Meeting of Shareholders for inclusion in the proxy statement and form of
proxy relating to that meeting is advised that the proposal must be received by
the Company at its principal executive offices not later than May 16, 2003. The
Company will not be required to include in its proxy statement or form of proxy
a shareholder proposal which is received after that date or which otherwise
fails to meet the requirements for shareholder proposals established by
regulations of the Securities and Exchange Commission.

In addition, if a shareholder intends to present a proposal at the
Company's 2003 Annual Meeting of Shareholders without the inclusion of that
proposal in the Company's proxy materials and written notice of the proposal is
not received by the Company on or before July 31, 2003, proxies solicited by the
Board of Directors for the 2003 Annual Meeting of Shareholders will confer
discretionary authority to vote on the proposal at the meeting.

OTHER MATTERS

This solicitation of proxies is made by and on behalf of the Board of
Directors. The cost of the solicitation will be borne by the Company. In
addition to solicitation by mail, proxies may be solicited by Directors,
officers and employees of the Company in person or by telephone, telegraph or
other means of communication. These persons will receive no additional
compensation for solicitation of proxies but may be reimbursed for reasonable
out-of-pocket expenses in connection with such solicitation. The Company has
retained MacKenzie Partners, Inc. at an estimated cost of $8,500, plus
reimbursement of expenses, to assist in its solicitation of proxies from
brokers, nominees, institutions and individuals. Arrangements will also be made
by the Company with custodians, nominees and fiduciaries for forwarding of proxy
solicitation materials to beneficial owners of shares held of record by such
custodians, nominees and fiduciaries, and the Company will reimburse such
custodians, nominees and fiduciaries for reasonable expenses incurred in
connection therewith.

If the enclosed proxy is executed and returned, or a proxy is voted by
telephone or Internet, the Common Shares represented thereby will be voted in
accordance with any specifications made by the shareholder. With respect to the
election of Directors, proxies returned without specifications made by the
shareholder will be voted to elect five Directors as set forth under "Election
of Directors" above.

The presence of any shareholder at the Annual Meeting will not operate
to revoke his or her proxy. A proxy may be revoked at any time insofar as it has
not been exercised by giving written notice to the Company or in open meeting or
by executing and forwarding a later-dated proxy to the Company or voting a later
proxy by telephone or Internet.

If any other matters shall properly come before the Annual Meeting, the
persons named in the proxy, or their substitutes, will vote thereon in
accordance with their judgment. The Board of Directors does not know of any
other matters which will be presented for action at the Annual Meeting.

By Order of the Board of Directors.

October 10, 2002 /s/ PAUL S. WILLIAMS, Secretary

APPENDIX A

Cardinal Health, Inc.
Audit Committee of the Board of Directors
Charter

I. PURPOSE

The primary function of the Audit Committee (the "Committee") is to
assist the Board of Directors of Cardinal Health, Inc. (the "Company") in
fulfilling its oversight responsibilities by reviewing: the financial reports
and other financial information provided by the Company to any governmental body
or the public; the Company's systems of internal controls regarding finance,
accounting, legal and code of ethics compliance that management and the Board of
Directors have established; and the Company's auditing, accounting and financial
processes generally. Consistent with this function, the Committee should
encourage continuous improvement of, and should foster adherence to, the
Company's policies, procedures and practices at all levels. The Committee's
primary duties and responsibilities are to:

- Serve as an independent and objective party to monitor the
Company's financial reporting processes and system of internal
accounting controls.

- Review and appraise the efforts of the Company's independent
accountants and its Corporate Auditing Department.

- Provide an open avenue of communication among the independent
accountants, financial and senior management, the Corporate
Auditing Department, and the Board of Directors.

The Committee will primarily fulfill these responsibilities by carrying out the
specific activities enumerated in Section IV. of this Charter and, upon the
direction and approval of the Board of Directors, to direct an investigation
into any activity of the Company. The Committee is empowered to retain persons
having special competence as necessary to assist the Committee in fulfilling its
responsibility.

II. COMPOSITION

The Committee has been created by the Board of Directors pursuant to the
authority of Section 1701.63, Ohio Revised Code, and Article 2, Section 2.18 of
the Company's code of regulations.

The Committee shall serve at the pleasure of the Board of Directors and shall be
subject to the control and direction of the Board of Directors.

The Committee shall be comprised of three or more directors as determined by the
Board of Directors, each of whom shall be independent directors, and free from
any relationship that, in the opinion of the Board of Directors, would interfere
with the exercise of his or her independent judgment as a member of the
Committee. The definition of independence of Committee members shall be
consistent with rules promulgated by the New York Stock Exchange. All members of
the Committee shall have a working familiarity with basic finance and accounting
practices, and at least one member of the Committee shall have accounting or
related financial management expertise, as specified by the Board of Directors.

The members of the Committee shall be elected by the Board of Directors and
serve until their successors shall be duly elected and qualified. Unless a Chair
is appointed by the Board of Directors, the members of the Committee may
designate a Chair by majority vote of the full Committee membership.

A-1

III. MEETINGS

The Committee shall meet at least four times annually, or more
frequently as circumstances dictate. As part of its job to foster open
communication, the Committee should meet at least annually with management, the
principal internal auditor and the independent accountants in separate executive
sessions to discuss any matters that the Committee or each of these groups
believe should be discussed privately.

IV. RESPONSIBILITIES AND DUTIES

To fulfill its responsibilities and duties, the Audit Committee shall:

DOCUMENTS/REPORTS REVIEW

1. Review and update this Charter periodically, at least annually, as
conditions dictate.
2. Review the Company's annual financial statements and any reports or other
financial information submitted to any governmental body, or the public,
including any certification, report, opinion, or review rendered by the
independent accountants.
3. Review summaries of reports to management prepared by the Corporate Auditing
Department and management's responses.
4. Review with financial management of the Company any public announcement of
financial results and SEC Form 10-Q or 10-K prior to its filing or public
release. The Chair of the Committee may represent the entire Committee for
purposes of this review.

INDEPENDENT ACCOUNTANTS

5. Recommend to the Board of Directors the selection of the independent
accountants, considering independence and effectiveness and approve the fees
and other compensation to be paid to the independent accountants. On an
annual basis, the Committee should review and discuss all significant
relationships the accountants have with the Company to determine the
accountants' independence. The Committee shall be responsible for ensuring
it receives from the independent accountants a formal written statement
delineating all relationships between the independent accountants and the
Company. The Committee is also responsible for actively engaging in a
dialogue with the independent accountants with respect to any disclosed
relationships or services that may impact their objectivity and independence
and for taking, or recommending that the full board take, appropriate action
to ensure such independence. The Committee shall review information on
non-audit services provided by the Company's independent accountants as
required by the SEC that will be disclosed in the Company's Notice of Annual
Meeting of Shareholders (Proxy Statement). Review of such information along
with discussions with the independent accountants will support the
Committee's statement in the Company's Proxy Statement that it... "has
considered whether the provision of non-audit services to the Company is
compatible with the independence of its independent accountants." Regarding
specific non-audit services provided by the Company's independent
accountants, the Committee has authorized its Chair to exercise authority to
approve such projects in excess of $250,000. The Committee along with the
Company's CEO must approve all non-audit service projects in excess of
$500,000.
6. Review the performance of the independent accountants in recognition that
the independent accountants are ultimately accountable to the Board of
Directors and the Committee as representatives of shareholders, and that as
such, they have the ultimate authority and responsibility to select,
evaluate, and where appropriate, replace the independent accountants.
7. Periodically consult with the independent accountants without the presence
of management about internal controls and the fullness and accuracy of the
Company's financial statements.

FINANCIAL REPORTING PROCESS

8. In consultation with the independent accountants and the corporate auditors,
review the integrity of the organization's financial reporting process, both
internal and external.

A-2

9. Consider the independent accountants' judgments about the quality and
appropriateness of the Company's accounting principles as applied in its
financial reporting.
10. Consider and approve, if appropriate, major changes to the Company's
auditing and accounting principles and practices as suggested by the
independent accountants, management, or the Corporate Auditing Department.

PROCESS IMPROVEMENT

11. Establish regular and separate systems of reporting to the Committee by each
of management, the independent accountants and the corporate auditors
regarding any significant judgments made in management's preparation of the
financial statements and the view of each as to the appropriateness of such
judgments.
12. Following completion of the annual audit, review separately with each of
management, the independent accountants and the corporate auditors any
significant difficulties encountered during the course of the audit,
including any restrictions on the scope of the work or access to required
information.
13. Review any significant disagreement among management and the independent
accountants which, if not resolved to the independent accountants'
satisfaction, would have caused them to issue a qualified report on the
Company's financial statements. "Disagreements" for this purpose shall be
those contemplated by item 304 of SEC Regulation S-K or successor rule.
14. Review with the independent accountants, the corporate auditors and
management the extent to which changes or improvements in financial or
accounting practices, as approved by the Committee, have been implemented.

ETHICAL AND LEGAL COMPLIANCE

15. Establish, review and update periodically a Code of Ethical Conduct and
ensure that management has established a system to enforce this code.
16. Review management's monitoring of the Company's compliance with the
organization's code of ethical conduct, and ensure that management has the
proper review system in place to ensure that the Company's financial
statements, reports and other financial information disseminated to
governmental organizations, and the public satisfy legal requirements.
17. Review activities, organizational structure, and qualifications of the
Corporate Audit Department.
18. Review, with the Company's internal counsel, legal compliance matters
including corporate securities trading policies.
19. Review, with the Company's internal counsel, any legal matter that could
have a significant impact on the Company's financial statements.
20. Perform any other activities consistent with the Charter, the Company's Code
of Regulations and governing law, as the Committee of the Board deems
necessary or appropriate.
21. Submit minutes of all audit committee meetings to the Board of Directors of
the Company.
22. Recommend to the Board of Directors any changes in the authority,
responsibility or duties of the Committee.

A-3

PROXY - CARDINAL HEALTH, INC.
7000 CARDINAL PLACE
DUBLIN, OHIO 43017

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

The undersigned hereby appoints Brendan A. Ford, Anthony J. Rucci and Paul S.
Williams, and each of them, the attorneys and proxies of the undersigned with
full power of substitution to vote as indicated herein all the common shares,
without par value, of Cardinal Health, Inc. held of record by the undersigned at
the close of business on September 9, 2002, at the annual meeting of
shareholders to be held on November 6, 2002, or any postponements or
adjournments thereof, with all the powers the undersigned would possess if then
and there personally present.

1. [ ] FOR all nominees listed (except as marked to the contrary) or
[ ] WITHHOLD AUTHORITY (to vote for all nominees listed):
THE BOARD RECOMMENDS A VOTE FOR THE NOMINEES LISTED BELOW.

J. MICHAEL LOSH, JOHN B. MCCOY, MICHAEL D. O'HALLERAN,
JEAN G. SPAULDING AND MATTHEW D. WALTER

(INSTRUCTION: TO WITHHOLD AUTHORITY TO VOTE FOR ANY INDIVIDUAL NOMINEE, WRITE
THAT NOMINEE'S NAME ON THE SPACE PROVIDED BELOW.)

--------------------------------------------------------------------------------

2. To transact such other business as may properly come before the meeting or
any adjournment or postponement thereof.

THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED AS SPECIFIED BY THE SHAREHOLDER.
IF NO SPECIFICATIONS ARE MADE, THE PROXY WILL BE VOTED TO ELECT THE NOMINEES
DESCRIBED IN ITEM 1 ABOVE, AND WITH DISCRETIONARY AUTHORITY ON ALL OTHER MATTERS
THAT MAY PROPERLY COME BEFORE THE ANNUAL MEETING OR ANY POSTPONEMENTS OR
ADJOURNMENTS THEREOF.

[PERFORATION]

[CONTROL NUMBER]

[THE TEXT SET FORTH BELOW IS NOT PART OF THE PROXY]

CARDINAL HEALTH, INC.
Dear Shareholder:

We encourage you to take advantage of two convenient ways by which you can vote
your shares. You may vote your shares electronically by touch-tone telephone or
via the Internet, which eliminates the need to return your proxy card.

VOTE BY TELEPHONE: To vote your shares by telephone, use a touch-tone telephone
and call the following toll-free number: 1-877-PRX-VOTE, 24 hours a day, 7 days
a week. Insert the Control Number printed in the box above, just below the
perforation. Follow the simple recorded instructions. You will incur no costs
for such call as this is a toll-free number.

VOTE BY INTERNET: To vote via the Internet, go to web site
WWW.EPROXYVOTE.COM/CAH. Type in the Control Number which is printed in the box
above, just below the perforation, and then follow the simple instructions.
Please be aware that if you vote over the Internet, you may incur costs such as
telecommunication and Internet access charges for which you will be responsible.

The Internet and telephone voting facilities will be available until 11:59 p.m.
(EST) on November 5, 2002, the day before Cardinal's Annual Meeting.

PLEASE DO NOT RETURN THE PROXY CARD IF YOU ARE VOTING BY TELEPHONE OR
THE INTERNET, AS THE PROXY CARD WILL REVOKE ANY PREVIOUSLY PROVIDED VOTE

By returning this proxy card you are conferring upon management the authority to
vote in their discretion upon such other business as may properly come before
the meeting or any postponement or adjournment thereof.

Receipt of Notice of Annual Meeting of Shareholders and the related Proxy
Statement is hereby acknowledged.

Dated , 2002
----------------------

-----------------------------------

-----------------------------------
Signature(s) of Shareholder(s)

Please sign as your name appears
hereon. If shares are held jointly,
all holders should sign. When
signing as attorney, executor,
administrator, trustee or guardian,
please give your full title. If a
corporation, please sign in full
corporate name by president or
other authorized officer. If a
partnership, please sign in
partnership name by authorized
person, indicating where proper,
official position or representative
capacity.

[PERFORATION]

[THE TEXT SET FORTH BELOW IS NOT PART OF THE PROXY]

[logo Cardinal Health]

ALL SHAREHOLDERS ARE URGED TO VOTE THEIR PROXY AS EARLY AS POSSIBLE.

PARTICIPANTS HOLDING SHARES THROUGH ANY OF THE COMPANY'S
EMPLOYEE BENEFIT PLANS ARE URGED TO VOTE THEIR SHARES
NO LATER THAN FRIDAY, NOVEMBER 1, 2002, IN ORDER TO
ENSURE COMPLETE VOTING BY THE APPLICABLE PLAN ADMINISTRATOR.

PLEASE SEE REVERSE SIDE FOR INFORMATION ON VOTING
YOUR PROXY BY TELEPHONE OR INTERNET.